The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)

Seminars in Cancer Biology

Volumn 22, Issue 2, 2012, Pages 144-153

  Dawson, Christopher W ^a   Port, Rebecca J ^a   Young, Lawrence S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

EBV; LMP1; LMP2; NPC

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; GLYCOGEN SYNTHASE KINASE 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; LATENT MEMBRANE PROTEIN 2B; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE; RANTES; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR FKHRL1; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UNCLASSIFIED DRUG; UVOMORULIN;

CARBOXY TERMINAL SEQUENCE; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; G1 PHASE CELL CYCLE CHECKPOINT; GENE LOCUS; HUMAN; MORPHOLOGY; NASOPHARYNX CARCINOMA; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSGENE;

CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; HERPESVIRUS 4, HUMAN; HUMANS; MODELS, BIOLOGICAL; NASOPHARYNGEAL NEOPLASMS; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS;

EID: 84857790848     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2012.01.004     Document Type: Review

References (159)

1. Young L.S., Rickinson A.B. Epstein-Barr virus: 40 years. Nat Rev Cancer 2004, 4:757-768.
2. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002, 12:431-441.
3. Pathmanathan R., Prasad U., Sadler R., Flynn K., Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995, 333:693-698.
4. Tsao S.W., Tramoutanis G., Dawson C.W., Lo A.K., Huang D.P. The significance of LMP1 expression in nasopharyngeal carcinoma. Semin Cancer Biol 2002, 12:473-487.
5. Wilson J.B., Weinberg W., Johnson R., Yuspa S., Levine A.J. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 1990, 61:1315-1327.
6. Morris M.A., Dawson C.W., Wei W., O'Neil J.D., Stewart S.E., Jia J., et al. Epstein-Barr virus-encoded LMP1 induces a hyperproliferative and inflammatory gene expression programme in cultured keratinocytes. J Gen Virol 2008, 89:2806-2820.
7. Li H.P., Chang Y.S. Epstein-Barr virus latent membrane protein 1: structure and functions. J Biomed Sci 2003, 10:490-504.
8. Zheng H., Li L.L., Hu D.S., Deng X.Y., Cao Y. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol 2007, 4:185-196.
9. Morris M.A., Dawson C.W., Young L.S. Role of the Epstein-Barr virus-encoded latent membrane protein 1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future Oncol 2009, 5:811-825.
10. Lee D.Y., Sugden B. The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy. Oncogene 2008, 27:2833-2842.
11. Kim K.R., Yoshizaki T., Miyamori H., Hasegawa K., Horikawa T., Furukawa M., et al. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene 2000, 19:1764-1771.
12. Mainou B.A., Everly D.N., Raab-Traub N. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 2005, 24:6917-6924.
13. Dawson C.W., Laverick L., Morris M.A., Tramoutanis G., Young L.S. Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J Virol 2008, 82:3654-3664.
14. Morris M.A., Young L.S., Dawson C.W. DNA tumour viruses promote tumour cell invasion and metastasis by deregulating the normal processes of cell adhesion and motility. Eur J Cell Biol 2008, 87:677-697.
15. Eliopoulos A.G., Gallagher N.J., Blake S.M., Dawson C.W., Young L.S. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem 1999, 274:16085-16096.
16. Zhang L., Wu L., Hong K., Pagano J.S. Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7. J Virol 2001, 75:12393-12401.
17. Eliopoulos A.G., Caamano J.H., Flavell J., Reynolds G.M., Murray P.G., Poyet J.L., et al. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κB2 to p52 via an IKKγ/NEMO-independent signalling pathway. Oncogene 2003, 22:7557-7569.
18. Luftig M., Yasui T., Soni V., Kang M.S., Jacobson N., Cahir-McFarland E., et al. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent non-canonical NF-κB activation. Proc Natl Acad Sci U S A 2004, 101:141-146.
19. Thornburg N.J., Raab-Traub N. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kB p50 homodimer/Bcl-3 complexes. J Virol 2007, 81:12954-12961.
20. Kung C.P., Raab-Traub N. Epstein-Barr virus latent membrane protein 1 modulates distinctive NF-kB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression. J Virol 2010, 84:6605-6614.
21. Izumi K.M., Kieff E.D. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB. Proc Natl Acad Sci USA 1997, 94:12592-12597.
22. Eliopoulos A.G., Rickinson A.B. Epstein-Barr virus: LMP1 masquerades as an active receptor. Curr Biol 1998, 8:R196-R198.
23. Eliopoulos A.G., Young L.S. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 1998, 16:1731-1742.
24. Kieser A., Kilger E., Gires O., Ueffing M., Kolch W., Hammerschmidt W. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J 1997, 16:6478-6485.
25. Eliopoulos A.G., Blake S.M., Floettmann J.E., Rowe M., Young L.S. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. J Virol 1999, 73:1023-1035.
26. Kieser A., Kaiser C., Hammerschmidt W. LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2. EMBO J 1999, 18:2511-2521.
27. Wan J., Zhang W., Wu L., Bai T., Zhang M., Lo K.W., et al. BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway. Mol Cell Biol 2006, 26:448-456.
28. Dawson C.W., Tramountanis G., Eliopoulos A.G., Young L.S. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodelling. J Biol Chem 2003, 278:3694-3704.
29. Mainou B.A., Everly D.N., Raab-Traub N. Unique signaling properties of CTAR1 in LMP1-mediated transformation. J Virol 2007, 81:9680-9692.
30. Kung C.P., Raab-Traub N. Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3. J Virol 2008, 82:5486-5493.
31. Kung C.P., Meckes D.G., Raab-Traub N. Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCδ. J Virol 2011, 85:4399-4408.
32. Yan G., Luo W., Lu Z., Luo X., Li L., Liu S., et al. Epstein-Barr virus latent membrane protein 1 mediates phosphorylation and nuclear translocation of annexin A2 by activating PKC pathway. Cell Signal 2007, 19:341-348.
33. Ning S., Pagano J.S., Barber G.N. IRF7: activation, regulation, modification and function. Genes Immun 2011, 12:399-414.
34. Huye L.E., Ning S., Kelliher M., Pagano J.S. Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination. Mol Cell Biol 2007, 27:2910-2918.
35. Ning S., Hahn A.M., Huye L.E., Pagano J.S. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit. J Virol 2003, 77:9359-9368.
36. Ning S., Pagano J.S. The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7. J Virol 2010, 84:6130-6138.
37. Chung P.J., Chang Y.S., Liang C.L., Meng C.L. Negative regulation of Epstein-Barr virus latent membrane protein 1-mediated functions by the bone morphogenetic protein receptor IA-binding protein. BRAM1 J Biol Chem 2002, 277:39850-43987.
38. Ikeda O., Sekine Y., Mizushima A., Oritani K., Yasui T., Fujimuro M., et al. BS69 negatively regulates the canonical NF-kappaB activation induced by Epstein-Barr virus-derived LMP1. FEBS Lett 2009, 583:1567-1574.
39. Ikeda O., Miyasaka Y., Yoshida R., Mizushima A., Oritani K., Sekine Y., et al. BS69 cooperates with TRAF3 in the regulation of Epstein-Barr virus-derived LMP1/CTAR1-induced NF-κB activation. FEBS Lett 2010, 584:865-872.
40. Ikeda O., Sekine Y., Yasui T., Oritani K., Sugiyma K., Muromoto R., et al. STAP-2 negatively regulates both canonical and noncanonical NF-κB activation induced by Epstein-Barr virus-derived latent membrane protein 1. Mol Cell Biol 2008, 28:5027-5042.
41. Lo K., Huang D. Genetic and epigenetic changes in nasopharyngeal carcinoma. Sem Cancer Biol 2002, 12:451-462.
42. Tao Q., Chan A.T. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 2007, 9:1-24.
43. Effert P., McCoy R., Abdel-Hamid M., Flynn K., Zhang Q., Busson P., et al. Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol 1992, 66:3768-3775.
44. Crook T., Nicholls J.M., Brooks L., O'Nions J., Allday M.J. High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?. Oncogene 2000, 19:3439-3444.
45. Fries K.L., Miller W.E., Raab-Traub N. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol 1996, 70:8653-8659.
46. Li L., Guo L., Tao Y., Zhou S., Wang Z., Luo W., et al. Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases. Cancer Lett 2007, 255:219-231.
47. Wu H.C., Lu T.Y., Lee J.J., Hwang J.K., Lin Y.J., Wang C.K., et al. MDM2 expression in EBV-infected nasopharyngeal carcinoma cells. Lab Invest 2004, 84:1547-1556.
48. Sheu L.F., Chen A., Lee H.S., Hsu H.Y., Yu D.S. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells. Pathol Int 2004, 54:475-485.
49. Man C., Rosa J., Lee L.T., Lee V.H., Chow B.K., Lo K.W., et al. Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells. Oncogene 2007, 26:3069-3080.
50. Macdiarmid J., Stevenson D., Campbell D.H., Wilson J.B. The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo. Carcinogenesis 2003, 24:1209-1218.
51. Yang X., Sham J.S., Ng M.H., Tsao S.W., Zhang D., Lowe S.W., et al. LMP1 of Epstein-Barr virus induces proliferation of primary mouse embryonic fibroblasts and cooperatively transforms the cells with a p16-insensitive CDK4 oncogene. J Virol 2000, 74:883-889.
52. Yang X., He Z., Xin B., Cao L. LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition ofp16INK4a expression. Oncogene 2000, 19:2002-2013.
53. Huang H., Huang P.C. Effects of two LMP1 variants on resistance of CNE1 cell strain to TGFβ1. Ai Zheng 2003, 22:1254-1259.
54. Lo A.K., Huang D.P., Lo K.W., Chui Y.L., Li H.M., Pang J.C., et al. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells. Int J Cancer 2004, 109:919-925.
55. Ohtani N., Brennan P., Gaubatz S., Sanij E., Hertzog P., Wolvetang E., et al. Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5. J Cell Biol 2003, 162:173-183.
56. Everly D.N., Mainou B.A., Raab-Traub N. Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J Virol 2004, 78:13470-13478.
57. Everly D.N., Mainou B.A., Raab-Traub N. The Id proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation. Virology 2008, 376:258-269.
58. Li H.M., Zhuang Z.H., Wang Q., Pang J.C., Wang X.H., Wong H.L., et al. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. Oncogene 2004, 23:4488-4494.
59. Lo A.K., Dawson C.W., Lo K.W., Yu Y., Young L.S. Upregulation of Id1 by Epstein-Barr virus-encoded LMP1 confers resistance to TGFβ-mediated growth inhibition. Mol Cancer 2010, 9:155.
60. Busson P., Braham K., Ganem G., Thomas F., Grausz D., Lipinski M., et al. Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin-1α Proc Natl Acad Sci U S A 1987, 84:6262-6266.
61. Huang Y.T., Sheen T.S., Chen C.L., Lu J., Chang Y., Chen J.Y., et al. Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells. Cancer Res 1999, 59:1599-1605.
62. Beck A., Päzolt D., Grabenbauer G.G., Nicholls J.M., Herbst H., Young L.S., et al. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease. J Pathol 2001, 194:145-151.
63. Huang Y.T., Liu M.Y., Tsai C.H., Yeh T.H. Upregulation of interleukin-1 by Epstein-Barr virus latent membrane protein 1 and its possible role in nasopharyngeal carcinoma cell growth. Head Neck 2010, 32:869-876.
64. Mee J.B., Johnson C.M., Morar N., Burslem F., Groves R.W. The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am J Pathol 2007, 171:32-42.
65. Miller W.E., Earp H.S., Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol 1995, 69:4390-4398.
66. Sheen T.S., Huang Y.T., Chang Y.L., Ko J.Y., Wu C.S., Yu Y.C., et al. Epstein-Barr virus-encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma. Jpn J Cancer Res 1999, 90:1285-1292.
67. Chen R.H., Chang M.C., Su Y.H., Tsai Y.T., Kuo M.L. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J Biol Chem 1999, 274:23013-32309.
68. Zheng Z., Pan J., Chu B., Wong Y.C., Cheung A.L., Tsao S.W. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol 1999, 30:458-466.
69. Fåhraeus R., Chen W., Trivedi P., Klein G., Obrink B. Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells. Int J Cancer 1992, 52(5):834-838.
70. Tsai C.N., Tsai C.L., Tse K.P., Chang H.Y., Chang Y.S. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the down-regulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci U S A 2002, 99:10084-10089.
71. Horikawa T., Yang J., Kondo S., Yoshizaki T., Joab I., Furukawa M., et al. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res 2007, 67:1970-1978.
72. Farwell D.G., McDougall J.K., Coltrera M.D. Expression of Epstein-Barr virus latent membrane proteins leads to changes in keratinocyte cell adhesion. Ann Otol Rhinol Laryngol 1999, 108:851-859.
73. Kang Y., Massagué J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004, 118:277-927.
74. Sides M.D., Klingsberg R.C., Shan B., Gordon K.A., Nguyen H.T., Lin Z., et al. The Epstein-Barr virus latent membrane protein 1 and transforming growth factor-β1 synergistically induce epithelial-mesenchymal transition in lung epithelial cells. Am J Respir Cell Mol Biol 2011, 44:852-862.
75. Horikawa T., Yoshizaki T., Kondo S., Furukawa M., Kaizaki Y., Pagano J.S. Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma. Brit J Cancer 2011, 104:1160-1167.
76. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009, 9:265-273.
77. Kondo S., Wakisaka N., Muramatsu M., Zen Y., Endo K., Murono S., et al. Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines. J Virol 2011, 85:11255-11264.
78. Yoshizaki T. Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1. Histol Histopathol 2002, 17:845-850.
79. Gou X.M., Chen Y., Chen X.Y., Arrand J.R. Effects of Epstein-Barr virus latent membrane protein 1(EBV-LMP1) on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1. Ai Zheng 2003, 22:481-485.
80. Lee D.C., Chua D.T., Wei W.I., Sham J.S., Lau A.S. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma. Biomed Pharmacother 2007, 61:520-526.
81. Horikawa T., Yoshizaki T., Sheen T.S., Lee S.Y., Furukawa M. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 2000, 89:715-723.
82. Khabir A., Karray H., Rodriguez S., Rosé M., Daoud J., Frikha M., et al. EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in North African nasopharyngeal carcinomas. Virol J 2005, 2:39.
83. Wakisaka N., Pagano J.S. Epstein-Barr virus induces invasion and metastasis factors. Anticancer Res 2003, 23:2133-2138.
84. Shen Z.H., Chen X.Y., Chen J. Impact of up-regulating Ezrin expression by Epstein-Barr virus latent membrane protein 1 on metastasis ability of nasopharyngeal carcinoma cells. Ai Zheng 2008, 27:165-169.
85. Liu L.T., Peng J.P., Chang H.C., Hung W.C. RECK is a target of Epstein-Barr virus latent membrane protein 1. Oncogene 2003, 22:8263-8270.
86. Shair K.H., Schnegg C.I., Raab-Traub N. Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch. Cancer Res 2009, 69:5734-5742.
87. Chang S.H., Chang H.C., Hung W.C. Transcriptional repression of tissue inhibitor of metalloproteinase-3 by Epstein-Barr virus latent membrane protein 1 enhances invasiveness of nasopharyngeal carcinoma cells. Oral Oncol 2008, 44:891-897.
88. Kondo S., Wakisaka N., Schell M.J., Horikawa T., Sheen T.S., Sato H., et al. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma. Int J Cancer 2005, 115:368-376.
89. Zeng L., Liu Y.P., Tao Y.G., Ai M.D., Zhao X.R., Cao Y. Cross-talk between c-Jun/Ets1 involved in EBV-encoded latent membrane protein 1 regulates expression of matrix metalloproteinase-9 in nasopharyngeal carcinoma. Zhonghua Zhong Liu Za Zhi 2005, 27:204-208.
90. Horikawa T., Sheen T.S., Takeshita H., Sato H., Furukawa M., Yoshizaki T. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am J Pathol 2001, 159:27-33.
91. Ben Nasr H., Chahed K., Remadi S., Zakhama A., Chouchane L. Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients. Arch Med Res 2009, 40:196-203.
92. Chew M.M., Gan S.Y., Khoo A.S., Tan E.L. Interleukins, laminin and Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) promote metastatic phenotype in nasopharyngeal carcinoma. BMC Cancer 2010, 10:574.
93. Kondo S., Yoshizaki T., Wakisaka N., Horikawa T., Murono S., Jang K.L., et al. MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling. J Virol 2007, 81:1554-1562.
94. Wakisaka N., Kondo S., Yoshizaki T., Murono S., Furukawa M., Pagano J.S. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1α. Mol Cell Biol 2004, 24:5223-5234.
95. Kondo S., Seo S.Y., Yoshizaki T., Wakisaka N., Furukawa M., Joab I., et al. EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells. Cancer Res 2006, 66:9870-9877.
96. Murono S., Inoue H., Tanabe T., Joab I., Yoshizaki T., Furukawa M., et al. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci U S A 2001, 98:6905-6910.
97. Bergers G. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000, 2:737-744.
98. Yoshizaki T., Horikawa T., Qing-Chun R., Wakisaka N., Takeshita H., Sheen T.S., et al. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma. Clin Cancer Res 2001, 7:1946-1951.
99. Ren Q., Sato H., Murono S., Furukawa M., Yoshizaki T. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the NF-κB signaling pathway in EBV-infected nasopharyngeal carcinoma cell line. Laryngoscope 2004, 114:855-859.
100. Eliopoulos A.G., Gallagher N.J., Blake S.M., Dawson C.W., Young L.S. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem 1999, 274:16085-16096.
101. Tsuji A., Wakisaka N., Kondo S., Murono S., Furukawa M., Yoshizaki T. Induction of receptor for advanced glycation end products by EBV latent membrane protein 1 and its correlation with angiogenesis and cervical lymph node metastasis in nasopharyngeal carcinoma. Clin Cancer Res 2008, 14:5368-5375.
102. Chen H.C., Chen G.H., Chen Y.H., Liao W.L., Liu C.Y., Chang K.P., et al. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer 2009, 100:1002-1011.
103. Sengupta S., den Boon J.A., Chen I.H., Newton M.A., Stanhope S.A., Cheng Y.J., et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A 2008, 105:5874-5878.
104. Li G., Wu Z., Peng Y., Liu X., Lu J., Wang L., et al. MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. Cancer Lett 2010, 299:29-36.
105. Du Z.M., Hu L.F., Wang H.Y., Yan L.X., Zeng Y.X., Shao J.Y., et al. Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS One 2011, 6:e19137.
106. Xia H., Ng S.S., Jiang S., Cheung W.K., Sze J., Bian X.W., et al. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun 2010, 391:535-541.
107. Baranwal S., Alahari S.K. miRNA control of tumor cell invasion and metastasis. Int J Cancer 2010, 126:1283-1290.
108. Edwards R.H., Seillier-Moiseiwitsch F., Raab-Traub N. Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology 1999, 261:79-95.
109. Chen M.L., Tsai C.N., Liang C.L., Shu C.H., Huang C.R., Sulitzeanu D., et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992, 7:2131-2140.
110. Hu L.F., Zabarovsky E.R., Chen F., Cao S.L., Ernberg I., Klein G., et al. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991, 72:2399-2409.
111. Hu L.F., Chen F., Zheng X., Ernberg I., Cao S.L., Christensson B., et al. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membraneprotein LMP1. Oncogene 1993, 8:1575-1583.
112. Miller W.E., Cheshire J., Baldwin A.S.J., Raab-Traub N. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells. Oncogene 1998, 16:1869-1877.
113. Dawson C.W., Eliopoulos A.G., Blake S.M., Barker R., Young L.S. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells. Virology 2000, 272:204-217.
114. Fielding C.A., Sandvej K., Mehl A., Brennan P., Jones M., Rowe M. Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways. J Virol 2001, 75:9129-9141.
115. Li S.N., Chang Y.S., Liu S.T. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 1996, 12:2129-2135.
116. Blake S.M., Eliopoulos A.G., Dawson C.W., Young L.S. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signaling activity. Virology 2001, 282:278-287.
117. Burrows J.M., Bromham L., Woolfit M., Piganeau G., Tellam J., Connolly G., et al. Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast Asia. J Virol 2004, 78:7131-7137.
118. Brooks L., Yao Q.Y., Rickinson A.B., Young L.S. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: co expression of EBNA1, LMP1, and LMP2 transcripts. J Virol 1992, 66:2689-2697.
119. Busson P., McCoy R., Sadler R., Gilligan K., Tursz T., Raab-Traub N. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol 1992, 66:3257-3262.
120. Heussinger N., Büttner M., Ott G., Brachtel E., Pilch B.Z., Kremmer E., et al. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma. J Pathol 2004, 203:696-699.
121. Kong Q.L., Hu L.J., Cao J.Y., Huang Y.J., Xu L.H., Liang Y., et al. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog 2010, 6:e1000940.
122. Sample J., Liebowitz D., Kieff E. Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J Virol 1989, 63:933-937.
123. Longnecker R. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?. Adv Cancer Res 2000, 79:175-200.
124. Pang M.F., Lin K.W., Peh S.C. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer. Cell Mol Biol Lett 2009, 14:222-247.
125. Rovedo M., Longnecker R. Epstein-Barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity. J Virol 2007, 81:84-94.
126. Longnecker R., Kieff E. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J Virol 1990, 64:2319-2326.
127. Dawson C.W., George J.H., Blake S.M., Longnecker R., Young L.S. The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1. Virology 2001, 289:192-207.
128. Lynch D.T., Zimmerman J.S., Rowe D.T. Epstein-Barr virus latent membrane protein 2B (LMP2B) co-localizes with LMP2A in perinuclear regions in transiently transfected cells. J Gen Virol 2002, 83:1025-1035.
129. Tomaszewski-Flick M.J., Rowe D.T. Minimal protein domain requirements for the intracellular localization and self-aggregation of Epstein-Barr virus latent membrane protein 2. Virus Genes 2007, 35:225-234.
130. Higuchi M., Izumi K.M., Kieff E. Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc Natl Acad Sci U S A 2001, 98:4675-4680.
131. Ikeda M., Longnecker R. Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability. Virology 2007, 360:461-468.
132. Katzman R.B., Longnecker R. LMP2A does not require palmitoylation to localize to buoyant complexes or for function. J Virol 2004, 78:10878-10887.
133. Portis T., Cooper L., Dennis P., Longnecker R. The LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease. Front Biosci 2002, 7:d414-d426.
134. Ikeda M., Ikeda A., Longan L.C., Longnecker R. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases. Virology 2000, 268:178-191.
135. Winberg G., Matskova L., Chen F., Plant P., Rotin D., Gish G., et al. Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases. Mol Cell Biol 2000, 20:8526-8535.
136. Ikeda A., Caldwell R.G., Longnecker R., Ikeda M. Itchy, a Nedd4 ubiquitin ligase, downregulates latent membrane protein 2A activity in B-cell signaling. J Virol 2003, 77:5529-5534.
137. Ikeda M., Longnecker R. The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling. Virology 2009, 385:183-191.
138. Panousis C.G., Rowe D.T. Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase. J Virol 1997, 71:4752-4760.
139. Scholle F., Longnecker R., Raab-Traub N. Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase. J Virol 1999, 73:4767-4775.
140. Miller C.L., Lee J.H., Kieff E., Longnecker R. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci U S A 1994, 91:772-776.
141. Miller C.L., Burkhardt A.L., Lee J.H., Stealey B., Longnecker R., Bolen J.B., et al. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 1995, 2:155-166.
142. Dykstra M.L., Longnecker R., Pierce S.K. Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity 2001, 14:57-67.
143. Moody C.A., Scott R.S., Su T., Sixbey J.W. Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence. J Virol 2003, 77:8555-8561.
144. Longan L., Longnecker R. Epstein-Barr virus latent membrane protein 2A has no growth-altering effects when expressed in differentiating epithelia. J Gen Virol 2000, 81:2245-2252.
145. Scholle F., Bendt K.M., Raab-Traub N. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates. Akt J Virol 2000, 74:10681-10689.
146. Morrison J.A., Raab-Traub N. Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling. J Virol 2005, 79:2375-2382.
147. Fukuda M., Longnecker R. Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt pathway. J Virol 2007, 81:9299-9306.
148. Allen M.D., Young L.S., Dawson C.W. The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility. J Virol 2005, 79:1789-1802.
149. Lu J., Lin W.H., Chen S.Y., Longnecker R., Tsai S.C., Chen C.L., et al. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J Biol Chem 2006, 281:8806-8814.
150. Fukuda M., Longnecker R. Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway. J Virol 2004, 78:1697-1705.
151. Moody C.A., Scott R.S., Amirghahari N., Nathan C.O., Young L.S., Dawson C.W., et al. Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A. J Virol 2005, 79:5499-5506.
152. Fotheringham J.A., Mazzucca S., Raab-Traub N. Epstein-Barr virus latent membrane protein-2A-induced DNp63alpha expression is associated with impaired epithelial-cell differentiation. Oncogene 2010, 29:4287-4296.
153. Carroll D.K., Carroll J.S., Leong C.O., Cheng F., Brown M., Mills A.A., et al. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol 2006, 8:551-561.
154. Pegtel D.M., Subramanian A., Sheen T.S., Tsai C.H., Golub T.R., Thorley-Lawson D.A. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol 2005, 79:15430-15442.
155. Anderson L.J., Longnecker R. An auto-regulatory loop for EBV LMP2A involves activation of Notch. Virology 2008, 371:257-266.
156. Man CH, Wei-Man Lun S, Wai-Ying Hui J, To KF, Choy KW, Wing-Hung Chan A, et al. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma; 2011. doi:10.1002/path.2997.
157. Kong Q.L, Hu L.J., Cao J.Y., Huang Y.J., Xu L.H., Liang Y., et al. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog 2010, 6:e1000940.
158. Shah K.M., Stewart S.E., Wei W., Woodman C.B., O'Neil J.D., Dawson C.W., et al. The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation. Oncogene 2009, 28:3903-3914.
159. Stewart S., Dawson C.W., Takada K., Curnow J., Moody C.A., Sixbey J.W., et al. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway. Proc Natl Acad Sci U S A 2004, 101:15730-15735.